1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsImmunology and Immunotherapy Research Funding Initiative (Proposition 38 - California) is sponsored by State of California. This is an initiated state statute on the ballot in California to authorize the state to issue $8. 4 billion in general obligation bonds to fund immunology and immunotherapy research.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Proposed Initiative Enters Circulation: Authorizes Bonds for Immunology Research. Initiative Statute. :: California Secretary of State Proposed Initiative Enters Circulation: Authorizes Bonds for Immunology Research.
Initiative Statute. Sacramento, Calif. – California Secretary of State Shirley N.
Weber, Ph. D. , announced that the proponent of a new initiative was cleared to begin collecting petition signatures on January 2, 2026.
The Attorney General prepares the legal title and summary that is required to appear on initiative petitions. When the official language is complete, the Attorney General forwards it to the proponent(s) and to the Secretary of State, and the initiative may be circulated for signatures. The Secretary of State then provides a calendar of deadlines to the proponent(s) and to county elections officials.
The Attorney General’s official title and summary for the measure is as follows: AUTHORIZES BONDS FOR IMMUNOLOGY RESEARCH. INITIATIVE STATUTE. Authorizes $8.
4 billion in state general obligation bonds for immunology and immunotherapy research (technologies that use body’s immune system to treat disease), allocated equally between (1) a University of California-affiliated nonprofit medical research institute selected by the California Department of Public Health based on specified criteria, and (2) a grant program for public or nonprofit universities and institutions.
Requires half of research money go to cancer, heart disease, and Alzheimer’s disease research. Requires funding recipients to sell technology and drugs derived from research in California for 20% below national average price. Appropriates money from General Fund to repay bonds.
Summary of estimate by Legislative Analyst and Director of Finance of fiscal impact on state and local governments: Increased state costs of about $500 million annually for 25 years to repay the bonds. The state could recoup part or all of this cost in subsequent decades if the funded research leads to discoveries that generate revenue, though this is uncertain. (25-0026A1.)
The Secretary of State’s tracking number for this measure is 2006 and the Attorney General's tracking number is 25-0026A1. The proponent of the measure, Gary K. Michelson, must collect signatures of 546,651 registered voters (five percent of the total votes cast for governor in the November 2022 general election) in order for the measure to become eligible for the ballot.
The proponent has 180 days to circulate petitions for the measure, meaning the signatures must be submitted to county elections officials no later than July 1, 2026. The address for the proponent is c/o Lance H. Olson, Aaron D.
Silva, and Benjamin Gevercer, Olson Remcho, LLP, 555 Capitol Mall, Suite 400, Sacramento, CA 95814. The proponent may also be contacted at (916) 442-2952, lolson@olsonremcho. com, asilva@olsonremcho.
com, and bgevercer@olsonremcho. com.
According to the current listing, eligibility includes: California-based public and nonprofit medical research institutions and a University of California-affiliated nonprofit medical research institute (if passed). Confirm the full requirements in the official notice before applying.
Applications for Immunology and Immunotherapy Research Funding Initiative (Proposition 38 - California) are due November 3, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Immunology and Immunotherapy Research Funding Initiative (Proposition 38 - California) is funded by State of California. Verify program details on the funder's official page before applying.
This opportunity targets applicants in California. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The FY2026 MEP Center State Competition ran in two rounds: eight states worth $139.1 million, then fourteen more worth $232.4 million, both closing August 21, 2026. That's 43 percent of the national network recompeted in twelve months, under a 50 percent non-federal cost share, while the administration's own budget request proposed eliminating the program. Here's what the award tables reveal, why incumbents are genuinely at risk, and how to position for the FY2027 wave.
Read articleOn August 14, 2026, the California Arts Council approved nearly $24.6 million across 1,200 grant awards. Buried in the release is a rare thing: before-and-after data showing exactly how much the ranked-priority bonus moved the pool. Small organizations went from 53% of applicants to 72% of awardees. Geography moved 19 points. First-time status barely moved at all. Here is what that means for the 2027 cycle.
Read articleThe California Civic Media Program is a $20 million public-private fund — $10 million from the state, $10 million matched by Google — that pays local newsrooms on a per-journalist formula: $20,000 for each of the first five FTE reporters, $10,000 for reporters six through twenty, capped at $250,000 per organization. Applications open July 6 and close August 21, 2026. Here is exactly how the formula works, which newsrooms qualify (and which are excluded), and how to position a small newsroom to win.
Read article